Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3060% below fair value
$3.07−0.02 (-0.65%)
Close on Nov 16, 2026Market cap $765.01MP/E –Yield –
Ardelyx EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Ardelyx's EV/EBITDA was 165.1× on Oct 30, 2015.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2015 | Oct 30, 2015 | 165.1× | +43.6 |
| 2014 | Dec 31, 2014 | 121.4× | – |
See a number that looks wrong?